Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinoma.

Brain metastases are a frequent feature of the course of non-small cell lung carcinoma (NSCLC). The potential usefulness of prophylactic cranial irradiation (PCI) has led to the search for target groups likely to derive benefit. This multivariate analysis looked for factors predictive of brain metastases in a group of stages I-III NSCLC patients under care of the thoracic oncology unit of Besançon University Hospital from 1977 to 2001. All the patients had the same follow-up. They were divided into two groups: BM+ when they had a brain metastasis as the first site of progression, whether solitary or not, and BM(-) otherwise. Variables analysed were age, gender, performance status (0-1 versus 2-3), weight-loss stage T-status, N-status, pathological type, type of treatment, administration of chemotherapy, use of cisplatin and response to treatment. Three hundred and five patients were eligible and there were 77 patients (25.25%) in the BM+ group. Median time to onset of brain metastases was 12 months (1-163 months) and median survival from the diagnosis of brain metastases was 6 months (1-65 months). Factors predictive of brain progression were age < or =62 years (RR: 2.5, 95% CI: 1.33-4.76 and P = 0.004), T4 tumour status (RR: 3.75, 95% CI: 1.72-8.21 and P = 0.0009), N2-3 (RR: 2.61, 95% CI: 1.32-5.15 and P = 0.0057), and adenocarcinoma (RR: 3.39, 95% CI: 1.78-6.46 and P = 0.0002). No aspect of treatment plays a role in the frequency of this type of metastasis. These factors predictive of brain progression could serve as a basis for the selection of patients with the aim of sitting of studies on prophylactic cranial irradiation in NSCLC.

[1]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[2]  R. Weichselbaum,et al.  Prophylactic cranial irradiation in adenocarcinoma of the lung a possible role , 1987, Cancer.

[3]  A. Carretta,et al.  Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment , 2002, Cancer.

[4]  T. J. Robnett,et al.  Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small-cell lung carcinoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  Y. Ichinose,et al.  The first site of recurrence after complete resection in non-small-cell carcinoma of the lung. Comparison between pN0 disease and pN2 disease. , 1994, The Journal of thoracic and cardiovascular surgery.

[6]  K. Yokoi,et al.  Brain metastasis in resected lung cancer: value of intensive follow-up with computed tomography. , 1996, The Annals of thoracic surgery.

[7]  C. Bucana,et al.  The seed and soil hypothesis: vascularisation and brain metastases. , 2002, The Lancet. Oncology.

[8]  M. O'connor,et al.  Is follow-up of lung cancer patients after resection medically indicated and cost-effective? , 1995, The Annals of thoracic surgery.

[9]  F. Lin,et al.  Impact of prophylactic cranial irradiation in adenocarcinoma of the lung. , 1993, Journal of the Formosan Medical Association = Taiwan yi zhi.

[10]  J. Cooper,et al.  Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group. , 1991, International journal of radiation oncology, biology, physics.

[11]  V. Budach,et al.  Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effects. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  A S Garden,et al.  Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation. , 1995, International journal of radiation oncology, biology, physics.

[13]  V. Rusch,et al.  Survival after resection of stage II non-small cell lung cancer. , 1992, The Annals of thoracic surgery.

[14]  R. D. Hunter,et al.  WHO Handbook for Reporting Results of Cancer Treatment , 1980 .

[15]  A. Depierre,et al.  Relevance of an intensive postoperative follow-up after surgery for non-small cell lung cancer. , 2000, Annals of Thoracic Surgery.

[16]  D. Booser,et al.  Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer , 1984, Journal of Neuro-Oncology.

[17]  K. Naunheim,et al.  Post‐Treatment Management Options for Patients with Lung Cancer , 1995, Annals of surgery.

[18]  J P Pignon,et al.  Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. , 1999, The New England journal of medicine.

[19]  F. André,et al.  Patterns of relapse of N2 nonsmall‐cell lung carcinoma patients treated with preoperative chemotherapy , 2001, Cancer.

[20]  D. Deheinzelin,et al.  Follow-up in lung cancer: how often and for what purpose? , 1999, Chest.

[21]  Z. Petrovich,et al.  Cranial irradiation in cancer of the lung of all cell types. , 1981, JAMA.

[22]  S. Gilbert,et al.  Who should follow up lung cancer patients after operation? , 2000, Annals of Thoracic Surgery.

[23]  V. Budach,et al.  Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  A. Twijnstra,et al.  Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma , 2002, Cancer.

[25]  C. Mountain,et al.  Revisions in the International System for Staging Lung Cancer. , 1997, Chest.